ClariVein OC - treatment for endovenous mechanochemical ablation

ClariVein® OC 5-Year Follow-up Results: Good Occlusion Rate, No Major Complications

Chronic venous insufficiency (CVI) in the legs, also known as varicose veins, is a relatively common condition, with worldwide prevalence ranging between 10% and 30%. Varicose veins can result in a number of symptoms, including pain, leg swelling, itching, and skin discoloration. Individuals with the condition may experience diminished quality of life and loss of work productivity. Finding treatment options that are effective and comfortable for the patient have been an area of interest in the endovascular community. ClariVein OC - treatment for endovenous mechanochemical ablation

A study by researchers in Verona, Italy, found that endovenous mechanochemical ablation (MOCA) treatment with the ClariVein® OC Infusion Catheter was associated with a good occlusion rate, comparable with other techniques, including thermal techniques, without major complications. This is one of the first reports in literature for MOCA treatment of symptomatic varicose veins with 5-year results. With little long-term data pertaining to this type of treatment, the aim of the study was to evaluate long-term occlusion rates.

This retrospective single-center study was published in Journal of Vascular Surgery: Venous and Lymphatic Disorders. Mirandola et al. treated 395 primary, symptomatic, unilateral, incompetent varicose saphenous veins in an outpatient setting. Of these patients, none were treated bilaterally in the same session. The majority of vessels treated were great saphenous veins (92.3%), and the others were small saphenous veins. Procedures were performed with the ClariVein OC and polidocanol 2% in liquid form.

A total of 329 patients were available for follow up, each treated between September 2012 and September 2017. Average follow-up time was 20 ± 18 months (range, 6-60 months). Results showed a technical success of 99.5%. Treatment was incomplete in two patients due to vein spasm, leading to catheter damage and inability to infuse the sclerosant. Follow up consisted of clinical evaluation and duplex ultrasound scan performed at 1 week, 1 month, 6 months, 1 year, and then once every year.

The overall survival rate free from recanalization was 92.4%. Anatomic success was 94% at 1 year, 91% at 2 years, 88% at 3 years, 88% at 4 years, and 84% at 5 years. The follow up at 5 years included 23 patients, five of whom presented with recanalization. The authors note that in this series, the veins completely disappeared on duplex ultrasound scan in 36% of cases.

It is interesting to note that after 89 patients, the researchers changed the way in which the sclerosant was injected. Beginning the infusion of sclerosant at point of mechanical pullback (protocol 2) produced higher occlusion rates compared to traditional ClariVein OC technique (protocol 1) with delayed infusion of sclerosant. Protocol 2 resulted in a change in cumulative survival rate free from recanalization from 92% to 97% (P ¼ 0.013).

Difference in anatomic success between 2 different protocolsFig 4. Difference in anatomic success between the two different protocols.

The researchers concluded that the ClariVein OC was associated with a good occlusion rate and was comparable with other techniques, including thermal techniques, without major complications.

Varicose veins occur when vessels are unable to pump blood back to the heart, causing the blood to pool, resulting in vessel enlargement over time. Under normal conditions, blood moves from the heart to the legs through the arteries and back to the heart through the veins. To accomplish this, the veins rely on surrounding muscles and a collection of valves to prevent blood from flowing backward. When these muscles and valves weaken or fail to work, blood begins to gather in the vein instead of returning to the heart.

In addition to pain, swelling, itching, and skin discoloration, other symptoms of varicose veins include:

  • Twisted and bulging veins
  • Aching, burning, throbbing and muscle cramping
  • Leg heaviness and fatigue

The ClariVein OC alleviates these symptoms by combining the power of a specialty infusion catheter with a rotating wire tip designed for the controlled 360-degree dispersion of physician-specified agents inside the targeted vessel. Requiring only a pin-sized entry through the skin, treatment with the ClariVein OC takes very little time, uses no heat or tumescent anesthesia, and creates minimal discomfort to the patient.

Learn more about the clinically proven ClariVein OC and how it can change the lives of your patients. Visit ClariVein.com or contact our Customer Support for more information.


IMPORTANT: This product page is intended only for an audience outside of the United States, as ClariVein OC is not approved, cleared, or available for sale in the United States. This product is not approved, cleared, or available for sale or use in the United States, and may not be approved, cleared, or available for sale or use in other countries. Please check with your country representative to determine which ClariVein catheters are available in your country. Please consult the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

ARTICLE REFERENCED:

Mirandola M et al. 2020. “An Italian Experience with Mechanochemical Ablation of the Saphenous Vein Since 2012.” J Vasc Surg Venous Lymphat Disord 8, no 6 (Nov): 999–1005. PMID: 32179039.

One-Vac Evacuated Drainage Bottle - Merit Medical

Meet the One-Vac™, Merit’s Newest Evacuated Drainage Bottle

One-Vac Evacuated Drainage Bottle - Merit MedicalMerit Medical is proud to announce the launch of the One-Vac Evacuated Drainage Bottle, the latest in evacuated drainage bottle technology. The smart option to aspirate, remove, or sample percutaneous fluids, the One-Vac is engineered with an advanced design that makes collection and discard simple, efficient, and safe.

The One-Vac is a valued addition to Merit’s Drainage portfolio and accompanies other premier products, such as the Aspira® Drainage System. This extension of the Drainage portfolio is the result of Merit’s commitment to continued innovation and dedication to providing clinicians with multiple high-quality product options when treating patients.

Read the press release.

Several key features are designed to make the One-Vac easy to use, helping to reduce the occurrence of common issues associated with bottle use. 

 

One-Vac Bottle has a number of design features that will provide lasting benefits to you and your patients

KEY FEATURES & BENEFITS

1 – Ergonomic Handle
Start, stop, and regulate flow. Easy to remove, minimizing spills during discard.

2 – Easy Sampling
Connect syringe and open handle to remove fluid for sampling.

3 – Bottle Neck
Easy to hold.

4 – Durable Plastic
Designed to prevent breakage.

5 – Faster Flow Rates
Provides 68% faster flow rates than competitive evacuated bottles.1

 

Learn more about the One-Vac Evacuated Drainage Bottle by exploring its product page or by connecting with our Customer Support Center to see how you can incorporate it and other Merit solutions into your practice today.


Before using, refer to the product Instructions for Use (IFU) for indications, contraindications, potential complications, warnings, precautions, and directions for use.

REFERENCES

1. Data on file.

Uterine Fibroid Embolization - Embosphere Microspheres

Embosphere® Results in Less Inflammatory Response, Lower Rates of Analgesic Use Compared to PVA After UFE

Merit Medical Brings Awareness to Men's Health

Merit Brings Awareness to Men’s Health During the Month of June

Merit Medical Exhibiting New Products & Education at SIR 2021

Merit Medical to Exhibit New Products and Must-See Educational Symposia During SIR 2021

National Kidney Month

Merit Recognizes National Kidney Month & World Kidney Day

SplashWire - It's Time to Reimagine Your Guide Wire

New SplashWire™ Delivers Superior Performance in Diagnostic and Interventional Procedures

ClariVein OC - Treatment for Varicose Veins - Outside US Only

ClariVein® OC Provides Varicose Vein Relief, Less Pain Than Radiofrequency Ablation, Similar Quality of Life Outcomes

SwiftNINJA Steerable Microcatheter - Merit Medical

SwiftNINJA® Overcomes Challenges of Selective Catheterization

WRAPSODY™ Inhibits Cell Migration, Tissue Accumulation Across Graft Layers, Helping to Maintain Vessel Patency

Surfacer Now Available In the United States - Merit Medical

Now Available in the US, Surfacer® System Provides Treatment Option for Venous Obstructions

Merit Medical Launches GO2WIRE™ Steerable Guide Wire System

The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

ReSolve ConvertX Limits Risk Exposure for Your Patients - Merit Medical - Stent Systems

ReSolve ConvertX® Simplifies Drainage Care, Limits Patient Exposure

Evolving Embolotherapy at Merit with Modernized Gelatin Foam - Understand. Innovate. Deliver.

Merit Modernizes Gelatin Foam with Torpedo and EmboCube Embolotherapy Products

Merit Medical - Your Partner in Drainage Solutions - Diverse, Innovative Drainage Solutions

With Ongoing Innovation, Merit Medical® Remains Your Partner in Drainage Care

Merit’s Newest Innovation in Health Care is Now Available

Merit Exists for People Like Karen Biehn

Charing Cross 2019

Charing Cross 2019